Profile: Amgen Inc. specializes in novel products based on recombinant DNA and molecular biology. Our Aranesp® is used for the treatment of anemia associated with chronic renal failure, as well as for the treatment of chemotherapy-induced anemia. Our Enbrel® is used for reducing the signs and symptoms of rheumatoid arthritis, polyarticular-course juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis & chronic moderate to severe psoriasis. Our Neulasta® is a recombinant protein that stimulates the production of infection-fighting white blood cells called neutrophils that are depleted by cytotoxic chemotherapy, a condition called neutropenia.
The company has revenues of USD 100-500 Million, has ~1200 employees and is CE certified. NASDAQ:IMNX (SEC Filings)
15 Products/Services (Click for related suppliers)
|
| • Alternative Arthritis Treatments |
| • Anti-acetylcholine Receptor Alpha Monoclonal Antibody |
| • Antibiotics |
| • Antibiotics Drugs |
| • Arthritis Treatments |
| • Beta-Lactam Antibiotics |
| • General Medical Supplies |
| • Lymphocyte Typing Control |
| • Miscellaneous Injectables |
| • Monoclonal Antibody Test |
| • Oncology & Cancer Treatments |
| • Psoriatic Arthritis Treatments |
| • Radioimmunoassay Test |
| • spinal arthritis treatments |
| • Syringe Holder Adapter (FDA Code: IQG / 890.5050) A daily activity assist device is a modified adaptor or utensil (e.g., a dressing, grooming, recreational activity, transfer, eating, or homemaking aid) that is intended for medical purposes to assist a patient to perform a specific function. |